Kyleena® – Demonstrated ease of insertion

Investigator evaluation of insertion procedure3*

In an open-label, phase III pivotal trial, study investigators reported that they found the procedure easy to perform in the following women:3


of all women


of nulliparous women


of parous women

The study included 1,452 women aged 18-35 including 39.5% (574) nulliparous women.3

Kyleena - Image of a Kyleena, zoomed in to show 3.8 mm tube.

* Results from a multi-centre international, open-label, randomized clinical study for 3 years with an extension to 5 years in 1,452 women aged 18-35 evaluating the contraceptive efficacy of Kyleena® (levonorgestrel-releasing intrauterine system [19.5 mg]).